IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)
2017
IKZF1 expression is a prognostic marker in newly diagnosed standard-risk
multiple myelomatreated with
lenalidomideand intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)
Keywords:
-
Correction
-
Source
-
Cite
-
Save
25
References
29
Citations
NaN
KQI